Dyadic International (DYAI) FCF Margin (2018 - 2026)
Dyadic International's (DYAI) quarterly FCF Margin came in at 176.72% in Q1 2026, up 31867.0% year-over-year from N/an in Q1 2025, and up 43.54% quarter-over-quarter from 313.0% in Q4 2025.
Analysis
Dyadic International (DYAI) FCF Margin (2018 - 2026) Analysis & Trends
Dyadic International has disclosed FCF Margin across 9 years of filings, most recently posting 176.72% for Q1 2026.
- In Q1 2026, FCF Margin rose 31867.0% year-over-year to 176.72%; the TTM figure through Mar 2026 stood at 150.11% (down 1474.0% YoY), while the FY2025 annual figure was 184.52%, down 7080.0% from the prior year.
- FCF Margin came in at 176.72% for Q1 2026 at Dyadic International, up from 313.0% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 10.27% in Q3 2024 to a low of 509.04% in Q2 2024.
- Average FCF Margin over 5 years is 251.87%, with a median of 223.6% recorded in 2023.
- The largest YoY upside for FCF Margin was 61497 bps in 2022 against a maximum downside of 20325982 bps in 2022.
- Over 5 years, FCF Margin stood at 226.13% in 2022, then soared by 41 bps to 134.5% in 2023, then soared by 37 bps to 85.2% in 2024, then plunged by 267 bps to 313.0% in 2025, then jumped by 44 bps to 176.72% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 176.72% in Q1 2026, 313.0% in Q4 2025, and 159.05% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 14.91% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -18,629.40% |
| 10 | Dyadic International | 17.78 Mn | 9.82 Mn | - | -176.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -176.72% |
| Dec 31, 2025 | -313.00% |
| Sep 30, 2025 | -159.05% |
| Jun 30, 2025 | -13.45% |
| Mar 31, 2025 | -495.39% |
| Dec 31, 2024 | -85.20% |
| Sep 30, 2024 | -10.27% |
| Jun 30, 2024 | -509.04% |
| Mar 31, 2024 | -332.61% |
| Dec 31, 2023 | -134.50% |
| Sep 30, 2023 | -494.06% |
| Jun 30, 2023 | -197.66% |
| Mar 31, 2023 | -223.60% |
| Dec 31, 2022 | -226.13% |
| Sep 30, 2022 | -201.93% |
| Jun 30, 2022 | -269.59% |
| Mar 31, 2022 | -439.58% |
| Dec 31, 2021 | -841.09% |
| Sep 30, 2021 | -625.48% |
| Jun 30, 2021 | 202,990.23% |